Skip to main content
. 2015 Feb 19;93(4):271–278. doi: 10.2471/BLT.14.141069

Table 1. Midterm progress in the health sector’s national strategic plan for 2009–2015, United Republic of Tanzania.

Health indicator Data source Baseline
Achievement
Target valuea Inequity
Year Value Year Value
Life expectancy for males/females, years PS/C 2002 51/52 2011 58/61 59/62 ND
Child mortality rate, deaths per 1000 live births PS/C 2004–2008 91 2006–2010 81 54 ND
Neonatal mortality rate, deaths per 1000 live births PS/C 2004–2008 29 2006–2011 26 19 ND
Infant mortality rate, deaths per 1000 live births PS/C 2004–2008 58 2006–2012 51 NS ND
Stunting among children younger than five years, % PS/C 2004–2005 38 2010 35 27 S, R and W
Underweight among children younger than five years, % PS/C 2004–2005 22 2010 14 14 ND
Maternal mortality ratio, deaths per 100 000 live births PS/C 1996–2005 578 2004–2010 454 156 ND
Total fertility rate, live births per woman PS/C 2003–2005 5.7 2008–2010 5.4 5.1 R and W
Adolescent fertility rate, % of women who either had a live birth or were pregnant with first child, before 20 years of age PS/C 2003–2005 52 2010 44 39 R and W
HIV prevalence, %
    Females/males aged 15–24 years PS/C 2008 3/1.1 2011–2012 2.8/1.2 NS S
    Pregnant women HFD 2005–2006 6.8 NA NA NS ND
    People aged15–49 years PS/C 2007–2008 5.8 2011–2012 5.3 NS ND
Tuberculosis notification rate, cases per 100 000 population HFD 2008 159 2011 142 NS S
Cholera incidence HFD 2008 2391 2011 343 0 ND
Cholera case fatality, % HFD 2008 3 2011 4 (98/2391) < 1 ND
Malaria prevalence among outpatients younger than five years, % HFD 2009 40 2012 33 NS ND
Prevalence of malarial parasitaemia among children younger than five years, % PS/C 2008 18 2012 9.2 5 ND
Coverage, % of target group
    Measles immunization (0–11 months) HFD 2008 91 2012 100 85 ND
    Third dose of diphtheria–tetanus–pertussis–Hib (0–11 months) HFD 2008 92 2012 95 85 ND
    Two-dose vitamin A (6–59 months) PS/C 2004–2005 46 2010 60 90 S and W
    Second dose of tetanus toxoid during pregnancy PS/C 2000–2005 5 2011 88 90 ND
First antenatal care visit at more than 16 weeks’ gestation, % of pregnant women PS/C 2000–2005 14 2006–2010 15 60 R
At least four antenatal care visits, % of pregnant women PS/C 2000–2005 64 2009–2010 36 90 R
Births in health facilities, % HFD 2007 51 2011 58 70 R and W
Skilled birth attendance, % of births PS/C 2000–2005 46 2010–2011 56 80 R and W
Contraceptive use, % of married women PS/C 2004–2005 20 2010 27 60 R and W
Use of insecticide-treated bednets by children/pregnant women, % PS/C 2008 26/27 2011–2012 73/75 80 ND
Two-dose intermittent preventive treatment against malaria, % of pregnant women PS/C 2008 30 2011–2012 31 80 ND
Prophylaxis for mother-to-child transmission of HIV, % coverage among pregnant women HFD NA NA 2011 71 80 ND
Antiretroviral coverage, % HFD NA NA 2012 65 60 ND
Tuberculosis treatment success rate, % HFD 2008 89 2011 88 85 ND
Government expenditure on health, % of total expenditure AD 2008–2009 12 2012 10 15 ND
Total health expenditure per capita, US$ AD 2008 26 2011 37 NS ND
Insurance coverage, % AD 2007 9 2012 14 80 ND
Health workforce, no. per 10 000 population
    Doctors and assistant medical officers AD 2004–2005 0.7 2012 0.9 NS ND
    Nurses and midwives AD 2004–2005 2.6 2012 4.9 NS ND
    Pharmacists AD 2004–2005 0.15 2012 0.12 NS ND
Outpatient visits per person-year AD 2012 0.78 2012 0.69 NS ND
Training institutes with full accreditation AD 2008 1 2012 56 30 ND
Basic emergency obstetric care, % of facilities HFD NA NA 2012 20 70 ND
Districts with timely surveillance reports, % AD 2008 60 2012 73 > 90 ND
No. of stockouts of tracer medicines and vaccines HFD 2006 0 2013 19 NS ND

AD: administrative data; HFD: health facility data; Hib: Haemophilus influenzae type b; HIV: human immunodeficiency virus; NA: not available; ND: none detected; NS: none set; PS/C: population survey or census; R: region of residence; S: sex; US$: United States Dollars; W: wealth quintile.

a To be achieved by the end of 2015.